Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 687-697, August 2007

Monitoring systemic lupus erythematosus in standard clinical care

  • Michelle Petri, MD, MPH (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 410 955 3823; Fax: +1 410 614 0498.

Johns Hopkins University School of Medicine, 1830 E Monument St Suite 7500, Baltimore, MD 21205, USA

published online 28 July 2007.

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a fluctuating and unpredictable course. Monitoring SLE in the routine clinic setting is a challenge because both the disease and its treatment can result in organ damage. Disease activity indices and a cumulative history summary can be used to track complicated patients over time. Monitoring guidelines for damage from the disease and for the toxicity of treatment are available.

Key words: flare, organ damage, SLE

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(07)00004-6

doi:10.1016/j.berh.2007.01.003

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 4 , Pages 687-697, August 2007

Article Tools

* Image Usage & Resolution